Navigation Links
Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
Date:6/2/2008

ytarabine (Ara-C) to cytarabine alone.

A second phase 3 study of clofarabine sponsored by the Eastern Cooperative Oncology Group is expected to begin enrolling patients next year. This study will compare single agent clofarabine to conventional induction chemotherapy in untreated AML patients age 60 and older who are considered suitable for conventional induction chemotherapy.

Clolar is indicated for the treatment of pediatric patients 1 to 21 years old with relapsed or refractory ALL after at least two prior regimens. This use is based on the induction of complete responses. Randomized trials demonstrating increased survival or other clinical benefit have not been conducted.

Genzyme also is actively exploring additional therapeutic indications for Clolar, including in MDS.

Genzyme Hosts Investor Call Tomorrow Morning

Genzyme will host an investor call tomorrow morning, Tuesday, June 3 at 10 a.m. EST. The preliminary data from the CLASSIC-II pivotal study will be reviewed and there will be opportunity for investors to ask questions of Genzyme.

To participate in the call, please dial 1-888-982-7287 in the U.S. or 1-210-234-0251 outside of the U.S. The participant passcode is "Genzyme."

A replay of this call will be available by dialing 1-800-695-3397. This call will also be available live on the investor events section of http://www.genzyme.com. Replays of the call will be available until 10:59 p.m. on June 10, 2008.

About Clolar

Clolar has Orphan Drug designation for adult and pediatric ALL, and seven years of market exclusivity in the United States for relapsed/refractory pediatric ALL. The FDA also granted six months of extended market exclusivity to Clolar under the Best Pharmaceuticals for Children Act.

Clolar should be administered under the supervision of a qualified physician experienced in the use of antineoplastic therapy. Suppression of
'/>"/>

SOURCE Genzyme Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
3. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
4. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
5. Pharmion and MethylGene Report Preliminary MGCD0103 Clinical Data at the 2007 AACR-NCI-EORTC International Conference
6. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
7. Vion Pharmaceuticals To Present Preliminary Data on its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) at the American Society of Hematology Meeting
8. Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
9. Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
10. Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients
11. A Functional Immune System Can Be Derived From Embryonic Stem Cells, Preliminary Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  Every day, their baby stopped ... to his lungs. April and Bryan Gionfriddo ... weren,t true. "Quite a few doctors said he ... says April Gionfriddo , about her now ... that would work, we would take it and run with ...
(Date:5/23/2013)... , May 23, 2013   Direct ... following mastectomy is an appropriate option for many ... to surgically reduce their breast cancer risk, or ... gradual expansion process and a second surgery to ... in the same surgery as mastectomy can be ...
(Date:5/23/2013)... TEL AVIV, Israel , May 23, 2013 ... of BrainTech Israel 2013 , Israel,s ... take place on October 14 th -15 th in ... 2 nd most innovative city in the world by ... the "Start-up Nation." BrainTech Israel 2013 will showcase ...
Breaking Medicine Technology:Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3
... Women About this Common Condition, MILWAUKEE, Sept. 13 ... Hyatt Regency Milwaukee hotel (333 West Kilbourn Avenue,Milwaukee) on ... to talk about her,experience with stress urinary incontinence (SUI). ... Breaking the Ice About SUI, a,national public education campaign. ...
... expertise on diseases transmitted between animals and humans,is ... City, Mo. Nearly half of the experts ... Sept. 17, are affiliated with K-State. The,symposium, at ... being,organized by the Kansas City Area Life Sciences ...
Cached Medicine Technology:Bonnie Blair to Break the Ice About Stress Urinary Incontinence in Milwaukee 2Bonnie Blair to Break the Ice About Stress Urinary Incontinence in Milwaukee 3K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security 2K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security 3
(Date:5/25/2013)... May 25, 2013 For college ... finals week. Increasingly, they are turning to prescription ... and study. For more on this, go to ... treatment facility, warns that students who pick up ... at risk for developing a physical and psychological ...
(Date:5/25/2013)... 2013 Superior Magnetics for Pain Free ... seconds for arthritis, tendinitis and bursitis , Pain Free ... products announced a magnetic bracelet so strong ... pain relief is demonstrated at fairs and festivals. This ... magnets and has customers often report pain relief in ...
(Date:5/25/2013)... http://www.resource4thepeople.com/defectivedrugs/Actos-Bladder-Cancer-Lawsuit.html , Resource4thePeople is ... of a jury's award of $6.5 million in damages ... the country over allegations that the diabetes drug Actos ... The judge in the case ruled that the man's ... was caused by the medication.** , Bloomberg News in ...
(Date:5/24/2013)... The special 35% off discount continues ... Sublime Beauty®. The products include a number of ... of the ingredients are in fact organic. , ... by many women," says Kathy Heshelow, founder of Sublime ... diminish their cellulite." The plan includes two specific products, ...
(Date:5/24/2013)... Part guidebook, part memoir, Peter Amato, M.A., ... true approach to meditation for the recovery community. Entitled ... Step, the book outlines a comprehensive method for recovering ... step in any 12-step recovery programs such as Alcoholics ... ever-growing global health problem affecting the physical and psychological ...
Breaking Medicine News(10 mins):Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2Health News:Magnetic bracelet relieves pain in seconds announces Superior Magnetics 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 2Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 3Health News:Alleged Actos Bladder Cancer Lawsuits Update: $6.5 Million Verdict Overturned as Resource4thePeople Attorneys Continue to Accept Cases 4Health News:"Get Ready for Summer Sale" at Sublime Beauty® Continues: New Cellulite Whisperer® Products 2Health News:Guidebook for Recovery Published by Meditation Master Peter Amato 2Health News:Guidebook for Recovery Published by Meditation Master Peter Amato 3
... ... today announced that McCormick & Company Vice President of Research & ... Trustees. Founded in 1974, Tai Sophia Institute is a nonprofit, ... first and only Master of Science in Herbal Medicine, as well ...
... ... nursing heroes. , ... MD (PRWEB) June 5, 2010 -- Nursefinders of Baltimore has announced an eight-week campaign that ... patients, family members or friends -- to nominate that person for recognition and a chance ...
... ... an innovative new table tent line called “Plastic Table Talkers”. Plastic Table Talkers can ... web site My1Stop.com. , ... (PRWEB) June 3, 2010 -- www.My1Stop.com launches innovative plastic table talkers ...
... and fish appears to lessen likelihood of wheeze, study ... who eat three or more hamburgers a week may raise ... , However, eating the so-called "Mediterranean diet" -- rich in ... the researchers say. , "Our results support previous reports that ...
... like to go on a mission to Mars? On ... chamber in Moscow for a simulated 520-day Mars mission conducted ... Institute for Biomedical Problems (IBMP) of the Russian Academy of ... than 90 experiments and realistic scenarios, including emergency situations, 20-minute ...
... ... growing Document Management Needs of New York Businesses and enable more Comprehensive Service Offerings ... ... in New York, NY, and Shoreline Records Management, a leader in Document Management based ...
Cached Medicine News:Health News:McCormick & Company Executive Joins Tai Sophia Institute Board of Trustees 2Health News:McCormick & Company Executive Joins Tai Sophia Institute Board of Trustees 3Health News:Nursefinders Announces “Best Nurses of Baltimore” Recognition Program 2Health News:My1Stop.com Launches Plastic Table Talkers -- Innovative Table Top Signs That Ship Flat and Outlast Traditional Acrylic Holders 2Health News:Burgers May Feed Kids' Asthma Risk 2Health News:Burgers May Feed Kids' Asthma Risk 3Health News:520-day Mars mission simulation 2Health News:520-day Mars mission simulation 3Health News:520-day Mars mission simulation 4Health News:Access Staffing and Shoreline Records Management Announce Strategic Alliance Partnership to Expand Document Management Services 2Health News:Access Staffing and Shoreline Records Management Announce Strategic Alliance Partnership to Expand Document Management Services 3Health News:Access Staffing and Shoreline Records Management Announce Strategic Alliance Partnership to Expand Document Management Services 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: